Article
Functional implications of a novel EA2 mutation in the P/Q‐type calcium channel
12 Jul 2004
Abstract excerpt
Episodic ataxia type 2 (EA2) is an autosomal dominant condition characterized by paroxysmal attacks of ataxia, vertigo, and nausea, typically lasting minutes to days in duration. These symptoms can be prevented or significantly attenuated by the oral administration of acetazolamide; however, the mechanism by which acetazolamide ameliorates EA2 symptoms is unknown. EA2 typically results from nonsense mutations in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
